Minapharm Pharmaceuticals (MIPH)

Currency in EGP
798.27
-31.13(-3.75%)
Closed·
Advertisement
MIPH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
793.00826.99
52 wk Range
263.001,000.00
Key Statistics
Bid/Ask
795.56 / 805.00
Prev. Close
798.27
Open
826.99
Day's Range
793-826.99
52 wk Range
263-1,000
Volume
1.65K
Average Volume (3m)
7.18K
1-Year Change
196.8209%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MIPH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Has maintained dividend payments for 20 consecutive years

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Earnings

Latest Release
17/08/2026
EPS / Forecast
5.29 / --
Revenue / Forecast
1.82B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 28.78%
Dividend Yield
0.30%
Industry Median 1.44%
Annualised payout
2.50
Paid unevenly
5-Years Growth
-24.55%
Growth Streak

Compare MIPH to Peers and Sector

Metrics to compare
MIPH
Peers
Sector
Relationship
P/E Ratio
30.7x14.2x−0.3x
PEG Ratio
0.060.520.00
Price/Book
1.5x3.2x2.6x
Price / LTM Sales
1.5x1.9x3.0x
Upside (Analyst Target)
-54.4%61.2%
Fair Value Upside
Unlock3.6%7.2%Unlock

MINAPHARM Pharmaceuticals produces medicines, chemicals, cosmetics, veterinary medical products, medical and dental supplies, nutritional supplements, and herbal medicines in Egypt and internationally. It operates through Bio-production, Drug production, and Other products. The company provides its products for the treatment of acne, alopecia, analgesics and anti-inflammation, atopic dermatitis, autoimmune disease, bone health, cardiovascular, cerebral insufficiency, diabetic neuropathy and retinopathy, dyslipidemia, gastroenterology and hepatology, glaucoma, hematoma and thrombosis, hemorrhoids, haemostasis, immuno-stimulants and immunomodulatory, and infertility, as well as for iron deficiency anemia, Ischemia, labour induction, menopause, nausea and vomiting, ocular infection and inflammation, osteoporosis, peripheral arterial, post operative management, pregnancy and lacation, probiotic and gut health, psoriasis, respiratory tract infection, rheumatoid arthritis, supplements, topical antibiotics, topical muscle relaxant, and venous disease. MINAPHARM Pharmaceuticals was founded in 1958 and is headquartered in Cairo, Egypt.

Market
Egypt

FAQ

What Is the Minapharm (Egypt: MIPH) Share Price Today?

The Minapharm stock price today is 798.27 EGP.

What Stock Exchange Does Minapharm (MIPH) Trade On?

Minapharm is listed and trades on the Egypt Stock Exchange.

What Is the Ticker (Stock Symbol) for Minapharm?

The stock symbol (also called a 'ticker') for Minapharm is "MIPH."

Does Minapharm Pay Dividends? What’s The Current MIPH Dividend Yield?

Yes, MIPH Pays Dividends to its Shareholders. The current Minapharm dividend yield is 0.3%.

What Is the Current Minapharm Market Capitalisation?

As of today, Minapharm (Egypt: MIPH) market cap is 9.77B EGP.

What Is Minapharm's (MIPH) Earnings Per Share (TTM)?

The Minapharm EPS is currently 28.78 (Trailing Twelve Months).

Is MIPH a Buy or Sell From a Technical Analyst Perspective?

Based on today's Minapharm moving averages and other technical indicators, the daily buy/sell signal for MIPH stock is Sell.

How Many Times Has Minapharm Stock Split?

Minapharm has split 3 times. (See the MIPH stock split history page for full effective split date and price information.)

What is the current trading status of Minapharm (Egypt: MIPH)?

As of 11/10/2026, Minapharm (MIPH) is trading at a share price of 798.27 EGP, with a previous close of 798.27 EGP. The stock has fluctuated within a day range of 793.00 EGP to 826.99 EGP, while its 52-week range spans from 263.00 EGP to 1,000.00 EGP.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.